BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1693865)

  • 1. Treatment of bladder carcinoma using a germ cell chemotherapy protocol.
    Williams G; Colbeck RA; Crawford SM
    Br J Urol; 1990 May; 65(5):473-7. PubMed ID: 1693865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is ectopic production of human chorionic gonadotrophin (hCG) or alpha fetoprotein (AFP) by tumours a marker of chemosensitivity?
    Crawford SM; Ledermann JA; Turkie W; Rustin GJ; Begent RH; Newlands ES; Bagshawe KD
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1483-7. PubMed ID: 2439342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
    Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic human chorionic gonadotrophin (HCG) production: is the detection by serum analysis of HCG of clinical relevance in transitional cell carcinoma of the bladder?
    Smith DJ; Evans HJ; Newman J; Chapple CR
    Br J Urol; 1994 Apr; 73(4):409-12. PubMed ID: 8199829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen and beta-human chorionic gonadotropin as serum markers for advanced urothelial malignancies.
    Dexeus F; Logothetis C; Hossan E; Samuels ML
    J Urol; 1986 Aug; 136(2):403-7. PubMed ID: 2426474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growth rate of metastatic nonseminomatous germ cell testicular tumours measured by marker production doubling time--II. Prognostic significance in patients treated by chemotherapy.
    Price P; Hogan SJ; Bliss JM; Horwich A
    Eur J Cancer; 1990 Apr; 26(4):453-7. PubMed ID: 1694087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy for metastatic urinary bladder cancer with 5-FU, vincristine, bleomycin, cyclophosphamide, mitomycin, and methotrexate.
    Kubota Y; Shuin T; Miura T; Moriyama M; Fukushima S; Shiozaki H; Ooshima H
    Cancer Treat Rep; 1984 Sep; 68(9):1167-8. PubMed ID: 6206946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour markers and POMB/ACE chemotherapy in the management of ovarian germ cell tumours (GCTs).
    Newlands ES; Holden L; Bagshawe KD
    Int J Biol Markers; 1988; 3(3):185-92. PubMed ID: 2466094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
    Mann JR; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendszus KR
    Cancer; 1989 May; 63(9):1657-67. PubMed ID: 2467734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UK Children's Cancer Study Group: testicular malignant germ cell tumours 1979-1988.
    Huddart SN; Mann JR; Gornall P; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendsus KR
    J Pediatr Surg; 1990 Apr; 25(4):406-10. PubMed ID: 1691781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gynecomastia and ectopic human chorionic gonadotropin production by transitional cell carcinoma of the bladder.
    Nishiyama T; Washiyama K; Tanikawa T; Mineyama H; Sasagawa T; Susuki H; Kitamura Y; Sato S
    Urol Int; 1992; 48(4):463-5. PubMed ID: 1413316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of a new combined primary chemotherapy regimen, intravenous methotrexate and vincristine and intraarterial adriamycin and cisplatin, for locally advanced urinary bladder cancer: preliminary results.
    Kuroiwa T; Naito S; Hasuo K; Kishikawa T; Masuda K; Kumazawa J
    Cancer Chemother Pharmacol; 1995; 35(5):357-63. PubMed ID: 7850915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in blood polyamine levels following chemotherapy in patients with invasive urinary bladder carcinoma].
    Taniguchi M; Minoshima K; Takeuchi T; Sakai S; Deguchi T; Kawada Y; Sato K; Hara A
    Nihon Hinyokika Gakkai Zasshi; 1998 Mar; 89(3):434-40. PubMed ID: 9577559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant chemotherapy following total cystectomy for invasive bladder cancer with bleomycin, vincristine and methotrexate].
    Takeuchi S; Yamada T; Sekine H; Katoh M; Washizuka M; Fukui I; Yokokawa M
    Hinyokika Kiyo; 1984 Nov; 30(11):1619-25. PubMed ID: 6084949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MEC treatment (methotrexate, etoposide, cisplatin) for urothelial cancer].
    Miura T; Murai T; Shimura H; Kondo I
    Gan To Kagaku Ryoho; 1992 May; 19(5):731-3. PubMed ID: 1580650
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
    Crawford SM; Newlands ES; Begent RH; Rustin GJ; Bagshawe KD
    Br J Cancer; 1989 Feb; 59(2):243-6. PubMed ID: 2467683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
    de Wit R; Sylvester R; Tsitsa C; de Mulder PH; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; van Oosterom AT; Boven E; Vermeylen K; Stoter G
    Br J Cancer; 1997; 75(3):432-5. PubMed ID: 9020492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic chemotherapy in advanced bladder cancer. New aspects].
    Jakse G
    Wien Klin Wochenschr; 1987 Jan; 99(2):54-7. PubMed ID: 3564487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer.
    Christensen TB; Engbaek F; Marqversen J; Nielsen SI; Kamby C; von der Maase H
    Br J Cancer; 1999 Jul; 80(10):1577-81. PubMed ID: 10408402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.